Sort   by:  
 Page size 
ModelsFox2002_IonicMechanism_CardiacMyocytes
This a model from the article: Ionic mechanism of electrical alternans. Fox JJ, McHarg JL, Gilmour RF Jr. Am J Physiol Heart Circ Physiol 2002 Feb;282(2):H516-30 11788399 , Abstract: Although alternans of...
2005-01-01 | MODEL0911665321 | BioModels
ModelsSaucerman2003_CardiacMyocyte_BetaAdrenergic
This a model from the article: Modeling beta-adrenergic control of cardiac myocyte contractility in silico. Saucerman JJ, Brunton LL, Michailova AP, McCulloch AD. J Biol Chem 2003 Nov 28;278(48):47997-8003 12972422 , Abstra...
2005-01-01 | MODEL1006230118 | BioModels
UnknownRandomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.
Not available
S-EPMC5569675 | biostudies-literature
UnknownTCF3 haploinsufficiency defined by immune, clinical, gene-dosage, and murine studies.
Not available
S-EPMC10527523 | biostudies-literature
ProteomicsThe ribotoxic stress response drives UV-mediated cell death.
Supporting raw MS data for paper (doi: 10.1016/j.cell.2024.05.018) by Sinha N.K. et al, titled "The ribotoxic stress response drives UV-mediated cell death". Index of MS files and labels Table S1 - HaCaT Timecourse. 1-1 - Proteome (AO3604-3627 | Unimod:35; 2016; 4 | 126 -UT_01; 127n - UT_02; 12...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2023-07-25 | MSV000092521 | MassIVE
UnknownTIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors.
Not available
S-EPMC12047497 | biostudies-literature
ProteomicsTIMEPOINT, a phase 1 study of MTL-CEBPA in combination with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumours.
Many cancer patients don’t benefit from currently-approved immune checkpoint inhibitors (ICI), suggesting that additional immunomodulation of the immunosuppressive tumour microenvironment (TME) is required. MTL-CEBPA specifically upregulates expression of master myeloid transcription factor, CEBPA, ...
ORGANISM(S): Homo sapiens (Human) 
2025-05-07 | PXD060726 | Pride
Human Cancer Plasma proteome Immunomodulatory 
ProteomicsTrans-Golgi protein TVP23B regulates host-microbe interactions via Paneth cell homeostasis and Goblet cell glycosylation
A key feature in intestinal immunity is the dynamic intestinal barrier, which separates the host from resident and pathogenic microbiota through a mucus gel impregnated with antimicrobial peptides. The mechanisms underlying the maintenance and function of this intestinal barrier are not completely ...
ORGANISM(S): Mus Musculus (ncbitaxon:10090) 
2022-12-12 | MSV000090883 | MassIVE
UnknownIntermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs.
Not available
S-EPMC9132770 | biostudies-literature
UnknownAutoantibodies against type I IFNs in patients with critical influenza pneumonia.
Not available
S-EPMC9485705 | biostudies-literature
Sort   by:  
 Page size